(PHRM) Phorm Inc
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 6517U Phorm Inc 28 December 2011 28 December 2011 Phorm, Inc. ("Phorm" or the "Company") Director Dealing
Phorm (AIM: PHRM and PHRX) announces that on December 28th Kent Ertugrul, CEO and Chairman of the Company, transferred for nil consideration 2,594,412 shares in the Company to Value Trust Holdings Pte Ltd limited for tax planning purposes.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 7763T Phorm Inc 12 December 2011 12 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Transfer of Shares
Phorm, Inc., (AIM: PHRX and PHRM), today announces that the Company has applied to AIM for the following shares to be transferred from the unrestricted line, trading under PHRX, to the restricted line, trading under PHRM.
Description of Security Old Ticker Symbol New Ticker Symbol No. of Shares ----------------------------- ------------------------ ------------------------- ----------------- Common Shares of $0.001 each PHRX PHRM 733
Following the transfer of these shares the Company still has a total of 75,491,515 issued and outstanding Common Shares trading on AIM, of which 74,682,990 will be in the restricted line, trading under PHRM, and 808,525 in the unrestricted line, trading under PHRX. 45,000 of the aforementioned PHRM Common Shares are held in treasury.
No new shares have been issued and dealings in the shares under the new ticker symbols are expected to commence on 13 December 2011.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb - ends - This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 07-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 5131T Phorm Inc 07 December 2011 7 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Transfer of Shares
Phorm, Inc., (AIM: PHRX and PHRM), today announces that the Company has applied to AIM for the following shares to be transferred from the unrestricted line, trading under PHRX, to the restricted line, trading under PHRM.
Description of Security Old Ticker Symbol New Ticker Symbol No. of Shares ----------------------------- ------------------------ ------------------------- ----------------- Common Shares of $0.001 each PHRX PHRM 24,693
Following the transfer of these shares the Company still has a total of 75,491,515 issued and outstanding Common Shares trading on AIM, of which 74,682,257 will be in the restricted line, trading under PHRM, and 809,258 in the unrestricted line, trading under PHRX. 45,000 of the aforementioned PHRM Common Shares are held in treasury.
No new shares have been issued and dealings in the shares under the new ticker symbols are expected to commence on 8 December 2011.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb - ends - This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 02-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 2766T Phorm Inc 02 December 2011
This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| 24-01-12 | ||||
|
|
||||
|
|
||||
|
13-12-11
Buy No Subject converse WOW ...........have you boys got real jobs HuhHuh? cant believe the usual culprits haven`t posted there usual often unfounded dribble on this forum today !!!!!!!!!!!! Anyway I`ll have a small wager with you guys, that apparently know so much about this stock, ........i reckon that the share price will hit £2 before it trades at 80p ..............what do you think? (actually dont answer that as i for one dont value any of your thoughts on this stock " lets see, look at http://uk.advfn.com/cmn/chrt/chrt_wrap.php?epic=PHRM&name=&type=1&sprd=0&size=2&period=13&freq=1&date1_day=13&date1_month=12&date1_year=2011&date2_day=24&date2_month=01&date2_year=2012&ind_type1=0&ind1_1=&ind2_1=&ind_type2=0&ind1_2=&ind2_2=&ind_type3=0&ind1_3=&ind2_3= seems you are in danger of losing came very close the last few days, so the spurts don't appear to have a clue either |
||||
| 17-01-12 | ||||
|
|
||||
|
|
||||
|
from advfn
Elsewhere Romtelecom is denying Phorm exists to their customers, http://forum.softpedia.com/index.php?showtopic=810348&st=180&p=10962521&#entry10962521 "There is no other claim in this regard. You are the only one advertising this." "Address a.oix.net has no connection with Romtelecom. You have installed a proxy and there is the problem." i seem to remember a BT customer being told he had a virus / malware, then buying a new pc to get the same result, then it started to come out about phorm (or 121 media as it was then) why do phorms ISP partners so want to distance themselves from phorm once customers start asking questions? is it the fact they have not understood how their customers may feel once they realise they are being spied on for the commercial gain of their ISP and phorm with no way to avoid the interception as the opt-out (when it shold be opt-in) is only for the advertising side not the interception? or is it that it is only once the ISP has the kit installed they see how it truely works? |
||||
| 12-01-12 | ||||
|
|
||||
|
|
||||
|
from another forum, curtesy flat tyre
EDITAIS DE INTIMAÇÃO ATO DE CONCENTRAÇÃO No 08012.010585/2010-29 REQUERENTE: TELEFÔNICA DATA S.A. E PHORM VEICULAÇÃO DE PUBLICIDADE LTDA. ADVOGADOS: GABRIEL DE CARVALHO JACINTHO, CAMILLA TEDESCHI DE TOLEDO TAPIAS, CAIO MÁRIO DA SILVA E OUTROS RELATOR: CONSELHEIRO RICARDO MACHADO RUIZ INTIMAÇÃO: De ordem, intimem-se as partes da juntada do voto condutor, nos termos do art. 94, parágrafo único do Regimento Interno do CADE, com redação dada pelo art. 6o da Resolução CADE n. 54/2010. - - Edit SUBPOENA In the merger 08012.010585/2010-29 APPLICANT: Telefonica Data SA and LTD Phorm ad placement. LAWYERS: GABRIEL DE CARVALHO Jacintha, CAMILLA TEDESCHI TAPIAS TOLEDO, Caio Mario da Silva and others SPEAKER: Ricardo Machado Ruiz ADVISOR SUBPOENA: In order to enjoin the voting shares of the attachment of the driver, according to art. 94, sole paragraph of the Internal CADE, with text provided by art. 6 of CADE Resolution No 54/2010. Article 94 is from, http://www.cade.gov.br/upload/Resolu%C3%A7%C3%A3o%20n%C2%BA%2054.pdf Art. 94. Nos casos em que houver necessidade de alteracoes no voto escrito do Conselheiro designado para a relatoria, os ajustes e a juntada do voto condutor aos autos deverao ser realizados ate a data da publicacao da ata de julgamento. Paragrafo unico. "Casos os referidos ajustes nao sejam realizados ate a data da publicacao da ata de julgament, o representante sera intimado da juntada da versao final do voto contendo a fundamentacao da decisao do Plenario do CADE. Da data da intimacao iniciarao os prazos de impugnacao. - - Article 94. Where there is need for alterations in the written vote of the Board assigned to the Rapporteur, the settings of the vote and joined the driver in the file should be achieved by the date of publication of the minutes of the trial. Single paragraph. "Cases such adjustments are not made until the date of publication of the minutes of the trial, the representative will be notified of the final version of the coupled containing the vote that the decision of the CADE. The date of the summons will start the time of challenge. so does this Imply that they may have decided to change the vote.... possibly as the result of a challenge. we wait and see |
||||
| 12-01-12 | ||||
|
|
||||
|
|
||||
|
Phorm mentioned in Class Action against Carrier IQ
http://webcache.googleusercontent.com/search?hl=en&tbo=1&tbs=qdr%3Ay,sbd%3A1&q=cache:lsTxhxGxFAYJ:http://docs.justia.com/cases/federal/district-courts/california/candce/5:2011cv05820/248886/1/0.pdf?ts=1323975398+phorm+filetype%3Apdf&ct=clnk http://docs.justia.com/cases/federal/district-courts/california/candce/5:2011cv05820/248886/1/0.pdf?ts=1323975398 h. Even without this IQ spyware, mobile phones are effectively tracking devices. But this latest discovery is ten times worse. This has to be highly illegal. Remember how British Telecom at first issues denials that their Phorm product was tracking web users, but then it was judged to be illegal. We need class-action law suits [sic] prosecute the phone manufacturers and the makers of this rootkit. i will leave you to decide if good or bad and for the pro phorm people, not the inclusion of the links to the article so others can verify information for them selves |
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Markets: The week that was (30/01-03/02/2012)Editor's Pick:
The week ahead...Editor's Pick:
Stock to Watch: Walker GreenbankEditor's Pick:
View from the top: Ortac Resources interviewEditor's Pick:
George Godber - Where to look for eurozone exposureEditor's Pick:
Buy-to-lets to steam ahead in 2012

